These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 32428508)

  • 21. Myofascia-dominant involvement on whole-body MRI as a risk factor for rapidly progressive interstitial lung disease in dermatomyositis.
    Karino K; Kono M; Kono M; Sakamoto K; Fujieda Y; Kato M; Amengual O; Oku K; Yasuda S; Atsumi T
    Rheumatology (Oxford); 2020 Jul; 59(7):1734-1742. PubMed ID: 31925431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of cytokine profiles between anti-ARS antibody-positive interstitial lung diseases and those with anti-MDA-5 antibodies.
    Asakawa K; Yoshizawa K; Aoki A; Kimura Y; Tanaka T; Ohashi K; Hayashi M; Kikuchi T; Sato S; Takada T
    Clin Rheumatol; 2020 Jul; 39(7):2171-2178. PubMed ID: 32056068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated carcinoembryonic antigen predicts rapidly progressive interstitial lung disease in clinically amyopathic dermatomyositis.
    Zhu D; Qiao J; Tang S; Pan Y; Li S; Yang C; Fang H
    Rheumatology (Oxford); 2021 Aug; 60(8):3896-3903. PubMed ID: 33398346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive factors and unfavourable prognostic factors of interstitial lung disease in patients with polymyositis or dermatomyositis: a retrospective study.
    Ji SY; Zeng FQ; Guo Q; Tan GZ; Tang HF; Luo YJ; Tang ZQ; Han YF
    Chin Med J (Engl); 2010 Mar; 123(5):517-22. PubMed ID: 20367973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction model for the pretreatment evaluation of mortality risk in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with interstitial lung disease.
    Gui X; Li W; Yu Y; Zhao T; Jin Z; Meng K; Wang R; Shi S; Yu M; Ma M; Chen L; Luan W; Xin X; Qiu Y; Qiu X; Zhang Y; Cao M; Cao M; Dai J; Cai H; Huang M; Xiao Y
    Front Immunol; 2022; 13():978708. PubMed ID: 36211445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive factors of rapidly progressive-interstitial lung disease in patients with clinically amyopathic dermatomyositis.
    Xu Y; Yang CS; Li YJ; Liu XD; Wang JN; Zhao Q; Xiao WG; Yang PT
    Clin Rheumatol; 2016 Jan; 35(1):113-6. PubMed ID: 26660480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HMGB1 May Be a Biomarker for Predicting the Outcome in Patients with Polymyositis /Dermatomyositis with Interstitial Lung Disease.
    Shu X; Peng Q; Lu X; Wang G
    PLoS One; 2016; 11(8):e0161436. PubMed ID: 27537498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two Distinct Immune Cell Signatures Predict the Clinical Outcomes in Patients With Amyopathic Dermatomyositis With Interstitial Lung Disease.
    Ye Y; Zhang X; Li T; Ma J; Wang R; Wu C; Wang R; Bao C; Ye S; Shen N; Guo Q; Fu Q; Zhang X
    Arthritis Rheumatol; 2022 Nov; 74(11):1822-1832. PubMed ID: 35713981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical significance of radiological patterns of HRCT and their association with macrophage activation in dermatomyositis.
    Zuo Y; Ye L; Liu M; Li S; Liu W; Chen F; Lu X; Gordon P; Wang G; Shu X
    Rheumatology (Oxford); 2020 Oct; 59(10):2829-2837. PubMed ID: 32065646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interstitial lung disease associated with amyopathic dermatomyositis: review of 18 cases.
    Ideura G; Hanaoka M; Koizumi T; Fujimoto K; Shimojima Y; Ishii W; Matsuda M; Ikeda S
    Respir Med; 2007 Jul; 101(7):1406-11. PubMed ID: 17353121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Initial limited three-level thin-section computed tomography scorings predict the prognosis of acute/subacute interstitial pneumonia in patients with dermatomyositis.
    Kotani T; Takeuchi T; Yoshimatsu Y; Ishida T; Yamamoto N; Fujiki Y; Oda K; Isoda K; Hata K; Kamimori T; Fujiwara H; Makino S; Hanafusa T
    Mod Rheumatol; 2016 Sep; 26(5):738-43. PubMed ID: 26707375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interstitial lung disease in clinically amyopathic dermatomyositis (CADM) patients: a retrospective study of 41 Chinese Han patients.
    Sun Y; Liu Y; Yan B; Shi G
    Rheumatol Int; 2013 May; 33(5):1295-302. PubMed ID: 23143553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinico-laboratory characteristics of patients with dermatomyositis accompanied by rapidly progressive interstitial lung disease.
    Ito M; Kaise S; Suzuki S; Kazuta Y; Sato Y; Miyata M; Nishimaki T; Nakamura N; Kasukawa R
    Clin Rheumatol; 1999; 18(6):462-7. PubMed ID: 10638771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical differences between interstitial lung disease associated with clinically amyopathic dermatomyositis and classic dermatomyositis.
    Mukae H; Ishimoto H; Sakamoto N; Hara S; Kakugawa T; Nakayama S; Ishimatsu Y; Kawakami A; Eguchi K; Kohno S
    Chest; 2009 Nov; 136(5):1341-1347. PubMed ID: 19581351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study.
    Ye S; Chen XX; Lu XY; Wu MF; Deng Y; Huang WQ; Guo Q; Yang CD; Gu YY; Bao CD; Chen SL
    Clin Rheumatol; 2007 Oct; 26(10):1647-54. PubMed ID: 17308858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients.
    Marie I; Hatron PY; Dominique S; Cherin P; Mouthon L; Menard JF
    Arthritis Rheum; 2011 Nov; 63(11):3439-47. PubMed ID: 21702020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pirfenidone in patients with rapidly progressive interstitial lung disease associated with clinically amyopathic dermatomyositis.
    Li T; Guo L; Chen Z; Gu L; Sun F; Tan X; Chen S; Wang X; Ye S
    Sci Rep; 2016 Sep; 6():33226. PubMed ID: 27615411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical analysis and outcome of interstitial lung disease complicated with juvenile dermatomyositis and juvenile polymyositis.
    Sato S; Uejima Y; Nanbu M; Suganuma E; Takano T; Tanaka R; Kabuki T; Oguma E; Oh-Ishi T; Kawano Y
    Mod Rheumatol; 2017 Jul; 27(4):652-656. PubMed ID: 27588444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interstitial lung disease in clinically amyopathic dermatomyositis with and without anti-MDA-5 antibody: to lump or split?
    Ikeda S; Arita M; Morita M; Ikeo S; Ito A; Tokioka F; Noyama M; Misaki K; Notohara K; Ishida T
    BMC Pulm Med; 2015 Dec; 15():159. PubMed ID: 26651481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Heterogeneity of Interstitial Lung Disease in Polymyositis and Dermatomyositis Patients With or Without Specific Autoantibodies.
    Chen F; Li S; Wang T; Shi J; Wang G
    Am J Med Sci; 2018 Jan; 355(1):48-53. PubMed ID: 29289262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.